Slingshot members are tracking this event:
FDA approves Gilead Sciences (GILD) Vosevi for the treatment of HCV genotypes 1 through 6
Slingshot Insights Explained
Jul 18, 2017
Don’t see a project related to the catalyst you care about?
Related Keywords Vosevi, Hcv, Genotype 1-6, Fda Approval